Maftivimab Antibody
Maftivimab (REGN3470-3471-3479), also known as Inmazeb, is an FDA-approved monoclonal antibody cocktail targeting the Zaire ebolavirus. It functions as a filovirus inhibitor and is applied in research for studying Ebola virus infection mechanisms, supported by in vitro neutralization and in vivo non-human primate efficacy studies.
Product Specifications
Target
Virus Protease
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Infectious Disease & Virology
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15341619 1 Vial
Lentiviral human S100G shRNA (UAS) - Lentiviral human S100G shRNA (UAS, RFP) (100)
Sign In for Pricing
View Details 
VAng-Lsx7218-1mgEcoli 1 mg (E. coli)
Recombinant Chlamydophila Trachomatis rpsM Protein (aa 1-122) (strain HAR-13 / ATCC VR-571B)
Sign In for Pricing
View Details